So what have you done for me lately?

For companies hoping to enter the big time of earnings stories, the stock performance of 12 companies that reported earnings last week is a reminder that simply hitting the analyst consensus numbers is not enough.

Of the major biotechs that put out first quarter numbers, eight beat their expected EPS, three hit the mark, and one missed. That could be seen as batting .920. However, of the eight that beat their number, half traded down on the week...